Pfizer Inc. (PFE) Q1 2020 Earnings Results

Pfizer Beats on EPS, Stock Down 1.1%

Pfizer's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by 1.1%, likely due to a lack of revenue information and no guidance updates. Investors may be cautious as the company navigates ongoing challenges in the market.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.80	N/A	+12.68%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Management expressed confidence in their ongoing projects and emphasized the importance of their research initiatives. They acknowledged the challenges posed by the current environment but remained optimistic about future developments.

We are focused on continuing our research and development efforts.

Our pipeline remains strong despite current challenges.

Pfizer Beats on EPS, Stock Down 1.1%

Key numbers

Management commentary

Pfizer Inc.

More earnings this week

Pfizer Beats on EPS, Stock Down 1.1%

Key numbers

Management commentary